Necessity of Interrupted Time Series Analysis in Evaluating the Impact of PHS Risk Identification and Introduction of Direct-Acting Antiviral Therapy and Share 35 Implementation.

Azab, Mohamed; Shah, Syed; Liu, Xibei; Shafi, Amaan; Al Dawoodi, Tamarah; Elmofti, Yousif; Froehlich, Mary; Ukken, Johnson; Yoo, Ji Won

Azab, Mohamed; Shah, Syed; Liu, Xibei; Shafi, Amaan; Al Dawoodi, Tamarah; Elmofti, Yousif; Froehlich, Mary; Ukken, Johnson; Yoo, Ji Won.

Afiliação

Azab M; Department of Internal Medicine, University of Nevada Las Vegas, Las Vegas, NV.
Shah S; Department of Internal Medicine, University of Nevada Las Vegas, Las Vegas, NV.
Liu X; Department of Medicine, College of Medicine, University of Arizona, Tuscon, AZ.
Shafi A; Department of Internal Medicine, University of Nevada Las Vegas, Las Vegas, NV.
Al Dawoodi T; Department of Internal Medicine, University of Nevada Las Vegas, Las Vegas, NV.
Elmofti Y; Department of Internal Medicine, University of Nevada Las Vegas, Las Vegas, NV.
Froehlich M; University of Nevada Reno School of Medicine, Reno, NV.
Ukken J; University of Nevada Reno School of Medicine, Reno, NV.
Yoo JW; Department of Internal Medicine, University of Nevada Las Vegas, Las Vegas, NV.

Transplantation ; 102(3): e122-e123, 2018 03.

Article em En | MEDLINE | ID: mdl-29319614

Assuntos

Antivirais; Análise de Séries Temporais Interrompida; Imunoterapia Adotiva; Manejo da Dor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Análise de Séries Temporais Interrompida Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google